Outset Medical, Inc. (OM) Stock Analysis & Investment Frameworks
Outset Medical, Inc. (OM) stock analysis on Invetso. Review Outset Medical, Inc.’s key financial metrics, company overview and 10 institutional-grade investment frameworks including SWOT Analysis, Economic Moat, Porter’s Five Forces and the Invetso Quality Score.
Outset Medical, Inc. Company Overview
- Exchange: NASDAQ Global Select
- Sector: Healthcare
- Industry: Medical - Devices
- Country: US
Outset Medical, Inc. Key Financial Metrics
- Market Cap: $76.13M
- Revenue: $119.48M
- ROE: -62.25%
- ROIC: -32.84%
- Dividend Yield: N/A
About Outset Medical, Inc.
Outset Medical, Inc. is a medical technology firm that specializes in developing hemodialysis systems. The company's primary product is the Tablo Hemodialysis System, a compact console designed to deliver dialysis treatment in various environments, including hospitals and patients' homes. This innovative system boasts integrated water purification, on-demand production of dialysate, and advanced software complete with connectivity features. Founded in 2003, the company initially operated under the name Home Dialysis Plus, Ltd. before rebranding to Outset Medical, Inc. in January 2015. Its corporate headquarters are located in San Jose, California.
Outset Medical, Inc. Investment Frameworks
Invetso analyzes Outset Medical, Inc. (OM) across the following frameworks:
- Outset Medical, Inc. 10Y Growth Potential
- Outset Medical, Inc. Scenario Analysis
- Outset Medical, Inc. Risks & Opportunities
- Outset Medical, Inc. Economic Moat
- Outset Medical, Inc. Business Model
- Outset Medical, Inc. Management
- Outset Medical, Inc. SWOT Analysis
- Outset Medical, Inc. Porter's 5 Forces
- Outset Medical, Inc. PESTLE Analysis
- Outset Medical, Inc. ESG Analysis